Network origin in Brant Schofield first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brant Schofield via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal | |
Alpharma Specialty Pharma LLC
 Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Part of Pfizer Inc., Alpharma Specialty Pharma LLC is a private company that distributes multi-source injectable pharmaceutical drugs. The company is based in Paramus, NJ. | Medical Distributors | Corporate Officer/Principal President | |
| AGILE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mayne Pharma, Inc.
 Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer President | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| SODASTREAM INTERNATIONAL LTD | Beverages: Non-Alcoholic | Director/Board Member | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| NATRA SA | Food: Specialty/Candy | Director/Board Member | |
| FIDELITY EMERGING MARKETS LIMITED | Investment Trusts/Mutual Funds | Director/Board Member | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
| East Carolina University | College/University | Graduate Degree Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Montclair State University | College/University | Undergraduate Degree | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lausanne | College/University | Masters Business Admin | |
PricewaterhouseCoopers (Australia)
 PricewaterhouseCoopers (Australia) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers (Australia) provides accounting and legal services. It offers asset management, consulting, indigenous consulting, and tax services. The company was founded in 1998 and is headquartered in Barangaroo, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Victoria University of Wellington | College/University | Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| Xintria Pharmaceutical Corp. | Chief Executive Officer | ||
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
Hindal Group of Cos.
 Hindal Group of Cos. Miscellaneous Commercial ServicesCommercial Services Part of UBS Group AG, Hindal Group of Cos. is a corporate advisory firm. The private company is based in Melbourne, Australia. Hindal Group of Cos. was acquired by Credit Suisse Group AG on October 29, 2008. | Miscellaneous Commercial Services | Director/Board Member | |
INMED Partnerships For Children
 INMED Partnerships For Children Miscellaneous Commercial ServicesCommercial Services INMED Partnerships For Children is a non-profit organization that provides health, nutrition, education, environmental, and social development services to support the development of healthy and educated children throughout the world. It offers family services, youth development, and education and skills building. The company was founded by Linda Pfeiffer in 1986 and is headquartered in Sterling, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Spirig Pharma AG
 Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ELCA Informatique SA
 ELCA Informatique SA Information Technology ServicesTechnology Services Part of ELCA Holding SA, ELCA Informatique SA is a company that provides high-quality, innovative solutions to the Swiss transportation industry and mobility providers to help them in their digital transformation. The private company is based in Lausanne, Switzerland, and the CEO of the company is Cédric Moret. The company has over 1700 specialists and 50+ years of experience, offering a unique spectrum of experience, skills, and technical innovations. ELCA advises various industries, including government institutions, financial services, energy, and healthcare, with state-of-the-art consulting services. | Information Technology Services | Director of Finance/CFO | |
Centenary Institute
 Centenary Institute Miscellaneous Commercial ServicesCommercial Services Centenary Institute operates as an independent medical research institute independent medical research institute. The firm offers research on cancer, inflammation, cardiovascular, research programs, laboratories and resources. The company was founded in 1982 and is headquartered in Camperdown, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
| Royal Australian College of General Practitioners | College/University | Chairman | |
| SmartPharma LLC | Founder | ||
| Temple University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| University of Sydney Business School | College/University | General Counsel | |
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | ||
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Pharmaceuticals BV
 Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Pharmaceuticals: Major | Director of Finance/CFO | |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the private company is based in Bristol, UK. | Medical Distributors | Director/Board Member | |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The private company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 22 |
| Switzerland | 10 |
| Australia | 9 |
| United Kingdom | 5 |
| Germany | 3 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Consumer Non-Durables | 4 |
| Distribution Services | 4 |
Operational
| Director/Board Member | 115 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 39 |
| Undergraduate Degree | 32 |
| President | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Viviane Monges | 21 |
| Bruce Robinson | 20 |
| Sandipkumar S. Kapadia | 19 |
| Frank Condella | 17 |
| Carolyn Myers | 16 |
| Hemanshu N. Pandya | 15 |
| Mark McCamish | 15 |
| Shawn O'Brien | 14 |
| Patrick Blake | 13 |
| Kathryn MacFarlane | 13 |
| James E. Goldschmidt | 12 |
| Peter Goldschmidt | 12 |
| Gregory Oakes | 12 |
| William Hodges | 11 |
| Torsten Koster | 9 |
- Stock Market
- Insiders
- Brant Schofield
- Company connections
